1. Home
  2. ARDX vs AAT Comparison

ARDX vs AAT Comparison

Compare ARDX & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • AAT
  • Stock Information
  • Founded
  • ARDX 2007
  • AAT 1967
  • Country
  • ARDX United States
  • AAT United States
  • Employees
  • ARDX N/A
  • AAT N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • AAT Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • AAT Real Estate
  • Exchange
  • ARDX Nasdaq
  • AAT Nasdaq
  • Market Cap
  • ARDX 1.3B
  • AAT 1.2B
  • IPO Year
  • ARDX 2014
  • AAT 2011
  • Fundamental
  • Price
  • ARDX $4.97
  • AAT $18.63
  • Analyst Decision
  • ARDX Strong Buy
  • AAT Hold
  • Analyst Count
  • ARDX 8
  • AAT 2
  • Target Price
  • ARDX $10.19
  • AAT $21.00
  • AVG Volume (30 Days)
  • ARDX 5.3M
  • AAT 497.6K
  • Earning Date
  • ARDX 05-01-2025
  • AAT 04-29-2025
  • Dividend Yield
  • ARDX N/A
  • AAT 7.30%
  • EPS Growth
  • ARDX N/A
  • AAT 12.42
  • EPS
  • ARDX N/A
  • AAT 0.94
  • Revenue
  • ARDX $333,615,000.00
  • AAT $453,339,000.00
  • Revenue This Year
  • ARDX $15.74
  • AAT $4.44
  • Revenue Next Year
  • ARDX $34.56
  • AAT $1.87
  • P/E Ratio
  • ARDX N/A
  • AAT $19.78
  • Revenue Growth
  • ARDX 168.06
  • AAT 3.79
  • 52 Week Low
  • ARDX $4.02
  • AAT $16.69
  • 52 Week High
  • ARDX $9.33
  • AAT $29.15
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 51.65
  • AAT 41.46
  • Support Level
  • ARDX $4.54
  • AAT $18.24
  • Resistance Level
  • ARDX $5.07
  • AAT $19.51
  • Average True Range (ATR)
  • ARDX 0.30
  • AAT 0.80
  • MACD
  • ARDX 0.06
  • AAT 0.12
  • Stochastic Oscillator
  • ARDX 82.74
  • AAT 68.62

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: